Physician profile
Michail Vasilakis
NPI 1356570287
$4,582.97
in general payments reported to CMS, 2019-2025
28 companies · $312 in 2025
The $312 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,398 · 2020: $540 · 2021: $465 · 2022: $275 · 2023: $205 · 2024: $387 · 2025: $312.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $853 · Entertainment: $30.46 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $853.45 |
| Entertainment | $30.46 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $1,367.43 | 2019-2025 | Senza, Excelsiusgps Robotic Navigation System, Excelsius Gps |
| Stryker Corporation | $836.37 | 2019 | |
| Abbott Laboratories | $569.49 | 2019-2025 | Proclaim, Eterna |
| Nevro Corp. | $383.02 | 2020-2024 | Senza |
| Si-Bone, INC. | $323.41 | 2019-2025 | |
| Intrinsic Therapeutics | $207.28 | 2022-2025 | Barricaid Acd (Annular Closure Device) |
| Medtronic, INC. | $154.04 | 2021-2025 | Aquamantys(Tm), Intellis Adaptivestim, Plasmablade(Tm) |
| Relievant Medsystems, INC. | $112.93 | 2020-2023 | Intracept |
| Portola Pharmaceuticals, LLC | $84.53 | 2019-2020 | |
| Providence Medical Technology, INC. | $72.83 | 2025 | |
| Medtronic USA, INC. | $68.41 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $56.38 | 2019-2022 | |
| Centinel Spine, LLC | $56.33 | 2019 | |
| Kuros Biosciences USA, INC | $30.46 | 2024 | Magnetos |
| Lemaitre Vascular, INC. | $28.48 | 2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Augmedics INC. | $22.64 | 2021 | |
| Csl Behring | $20.00 | 2024 | Kcentra |
| Radius Health, INC. | $19.29 | 2020 | |
| Boston Scientific Corporation | $18.73 | 2021 | |
| Mallinckrodt Enterprises LLC | $18.58 | 2019 | |
| Merck Sharp & Dohme LLC | $18.15 | 2021 | |
| Adamas Pharmaceuticals, INC. | $18.14 | 2019 | |
| Depuy Synthes Sales INC. | $17.98 | 2021 | |
| Baxter Healthcare | $17.54 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $17.45 | 2021 | |
| Integra Lifesciences Corporation | $15.86 | 2019 | |
| Arbor Pharmaceuticals, INC. | $15.70 | 2020 | |
| Davol INC. | $11.52 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michail Vasilakis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.